Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial. Cosentino F, Cannon CP, Frederich R, Cherney DZI, et al. Circulation 2022;146:652-654.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cosentino F, Cannon CP, Frederich R, Cherney DZI, et al. Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial. Circulation 2022;146:652-654.
PMID: 35994565